4//SEC Filing
Hermelin David S 4
Accession 0001140361-11-045457
CIK 0000057055other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 2:48 PM ET
Size
5.1 KB
Accession
0001140361-11-045457
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA / KVB
Hermelin David S
DirectorVice PresidentOther
Transactions
- Award
Option to Purchase
2011-09-08+20,000→ 20,000 totalExercise: $1.49Exp: 2021-09-08→ Class A Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal installments beginning September 8, 2012.
Documents
Issuer
KV PHARMACEUTICAL CO /DE/
CIK 0000057055
Entity typeother
Related Parties
1- filerCIK 0001296276
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 2:48 PM ET
- Size
- 5.1 KB